Protein kinase C ζ is required for epidermal growth factor-induced chemotaxis of human breast cancer cells

Ronghua Sun, Ping Gao, Lin Chen, Dalong Ma, Jiming Wang, Joost J. Oppenheim, Ning Zhang

Research output: Contribution to journalArticle

Abstract

Chemotaxis plays an important role in cancer cell metastasis. In this study, we showed that epidermal growth factor (EGF) was a more potent chemoattractant than chemokine SDF-1α/ CXCL12 for human breast cancer cell MDA-MB-231. Different inhibitors were used to evaluate the involvement of 12 protein kinase C (PKC) isotypes in the chemotactic signaling pathway. Chelerythrine chloride, an inhibitor of all PKC isotypes, blocked chemotaxis, whereas inhibitors of classic and novel PKC, such as Gö6976, Gö6850, or calphostin C, only impaired EGF-induced chemotaxis to a minor extent by ≯32% inhibition. These data suggested that atypical PKC were involved. The ligand-indueed actin polymerization and cell adhesion were also similarly dependent on atypical PKC. Immunofluorescent staining showed an EGF-induced, LY294002-sensitive translocation of PKCζ from the cytosol to the plasma membrane, indicating that EGF was capable of activating PKCζ, probably via phosphoinositide 3 kinases. A myristoylated PKCζ pseudosubstrate blocked the chemotaxis with an IC50 of 20 μmol/L. To expand our investigation, we further showed that in MCF-7 and T47D, two additional human breast cancer cell lines, EGF-activated PKCζ and the PKCζ pseudosubstrate, inhibited chemotaxis. Taken together, our data suggest that PKCζ is an essential component of the EGF-stimulated chemotactic signaling pathway in human breast cancer cells.

Original languageEnglish (US)
Pages (from-to)1433-1441
Number of pages9
JournalCancer Research
Volume65
Issue number4
DOIs
StatePublished - Feb 15 2005
Externally publishedYes

Fingerprint

Chemotaxis
Epidermal Growth Factor
Protein Kinase C
Breast Neoplasms
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
1-Phosphatidylinositol 4-Kinase
Chemotactic Factors
Chemokines
Cell Adhesion
Polymerization
Cytosol
Inhibitory Concentration 50
Actins
Cell Membrane
Staining and Labeling
Neoplasm Metastasis
Ligands
Cell Line

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Protein kinase C ζ is required for epidermal growth factor-induced chemotaxis of human breast cancer cells. / Sun, Ronghua; Gao, Ping; Chen, Lin; Ma, Dalong; Wang, Jiming; Oppenheim, Joost J.; Zhang, Ning.

In: Cancer Research, Vol. 65, No. 4, 15.02.2005, p. 1433-1441.

Research output: Contribution to journalArticle

Sun, Ronghua ; Gao, Ping ; Chen, Lin ; Ma, Dalong ; Wang, Jiming ; Oppenheim, Joost J. ; Zhang, Ning. / Protein kinase C ζ is required for epidermal growth factor-induced chemotaxis of human breast cancer cells. In: Cancer Research. 2005 ; Vol. 65, No. 4. pp. 1433-1441.
@article{2dc3b1dc5cc1457bbbfb49d4ac0097f9,
title = "Protein kinase C ζ is required for epidermal growth factor-induced chemotaxis of human breast cancer cells",
abstract = "Chemotaxis plays an important role in cancer cell metastasis. In this study, we showed that epidermal growth factor (EGF) was a more potent chemoattractant than chemokine SDF-1α/ CXCL12 for human breast cancer cell MDA-MB-231. Different inhibitors were used to evaluate the involvement of 12 protein kinase C (PKC) isotypes in the chemotactic signaling pathway. Chelerythrine chloride, an inhibitor of all PKC isotypes, blocked chemotaxis, whereas inhibitors of classic and novel PKC, such as G{\"o}6976, G{\"o}6850, or calphostin C, only impaired EGF-induced chemotaxis to a minor extent by ≯32{\%} inhibition. These data suggested that atypical PKC were involved. The ligand-indueed actin polymerization and cell adhesion were also similarly dependent on atypical PKC. Immunofluorescent staining showed an EGF-induced, LY294002-sensitive translocation of PKCζ from the cytosol to the plasma membrane, indicating that EGF was capable of activating PKCζ, probably via phosphoinositide 3 kinases. A myristoylated PKCζ pseudosubstrate blocked the chemotaxis with an IC50 of 20 μmol/L. To expand our investigation, we further showed that in MCF-7 and T47D, two additional human breast cancer cell lines, EGF-activated PKCζ and the PKCζ pseudosubstrate, inhibited chemotaxis. Taken together, our data suggest that PKCζ is an essential component of the EGF-stimulated chemotactic signaling pathway in human breast cancer cells.",
author = "Ronghua Sun and Ping Gao and Lin Chen and Dalong Ma and Jiming Wang and Oppenheim, {Joost J.} and Ning Zhang",
year = "2005",
month = "2",
day = "15",
doi = "10.1158/0008-5472.CAN-04-1163",
language = "English (US)",
volume = "65",
pages = "1433--1441",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "4",

}

TY - JOUR

T1 - Protein kinase C ζ is required for epidermal growth factor-induced chemotaxis of human breast cancer cells

AU - Sun, Ronghua

AU - Gao, Ping

AU - Chen, Lin

AU - Ma, Dalong

AU - Wang, Jiming

AU - Oppenheim, Joost J.

AU - Zhang, Ning

PY - 2005/2/15

Y1 - 2005/2/15

N2 - Chemotaxis plays an important role in cancer cell metastasis. In this study, we showed that epidermal growth factor (EGF) was a more potent chemoattractant than chemokine SDF-1α/ CXCL12 for human breast cancer cell MDA-MB-231. Different inhibitors were used to evaluate the involvement of 12 protein kinase C (PKC) isotypes in the chemotactic signaling pathway. Chelerythrine chloride, an inhibitor of all PKC isotypes, blocked chemotaxis, whereas inhibitors of classic and novel PKC, such as Gö6976, Gö6850, or calphostin C, only impaired EGF-induced chemotaxis to a minor extent by ≯32% inhibition. These data suggested that atypical PKC were involved. The ligand-indueed actin polymerization and cell adhesion were also similarly dependent on atypical PKC. Immunofluorescent staining showed an EGF-induced, LY294002-sensitive translocation of PKCζ from the cytosol to the plasma membrane, indicating that EGF was capable of activating PKCζ, probably via phosphoinositide 3 kinases. A myristoylated PKCζ pseudosubstrate blocked the chemotaxis with an IC50 of 20 μmol/L. To expand our investigation, we further showed that in MCF-7 and T47D, two additional human breast cancer cell lines, EGF-activated PKCζ and the PKCζ pseudosubstrate, inhibited chemotaxis. Taken together, our data suggest that PKCζ is an essential component of the EGF-stimulated chemotactic signaling pathway in human breast cancer cells.

AB - Chemotaxis plays an important role in cancer cell metastasis. In this study, we showed that epidermal growth factor (EGF) was a more potent chemoattractant than chemokine SDF-1α/ CXCL12 for human breast cancer cell MDA-MB-231. Different inhibitors were used to evaluate the involvement of 12 protein kinase C (PKC) isotypes in the chemotactic signaling pathway. Chelerythrine chloride, an inhibitor of all PKC isotypes, blocked chemotaxis, whereas inhibitors of classic and novel PKC, such as Gö6976, Gö6850, or calphostin C, only impaired EGF-induced chemotaxis to a minor extent by ≯32% inhibition. These data suggested that atypical PKC were involved. The ligand-indueed actin polymerization and cell adhesion were also similarly dependent on atypical PKC. Immunofluorescent staining showed an EGF-induced, LY294002-sensitive translocation of PKCζ from the cytosol to the plasma membrane, indicating that EGF was capable of activating PKCζ, probably via phosphoinositide 3 kinases. A myristoylated PKCζ pseudosubstrate blocked the chemotaxis with an IC50 of 20 μmol/L. To expand our investigation, we further showed that in MCF-7 and T47D, two additional human breast cancer cell lines, EGF-activated PKCζ and the PKCζ pseudosubstrate, inhibited chemotaxis. Taken together, our data suggest that PKCζ is an essential component of the EGF-stimulated chemotactic signaling pathway in human breast cancer cells.

UR - http://www.scopus.com/inward/record.url?scp=13944272618&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13944272618&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-04-1163

DO - 10.1158/0008-5472.CAN-04-1163

M3 - Article

C2 - 15735031

AN - SCOPUS:13944272618

VL - 65

SP - 1433

EP - 1441

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 4

ER -